Showing 441 - 460 results of 491 for search '(( 12 c decrease ) OR ( 5 ((teer decrease) OR (((we decrease) OR (mean decrease)))) ))', query time: 0.20s Refine Results
  1. 441

    Health in times of uncertainty in the eastern Mediterranean region, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 by Mokdad, Ali H

    Published 2016
    “…In this systematic analysis, we use data from GBD 2013 to analyse the burden of disease and injuries in the eastern Mediterranean region specifically. …”
    Get full text
    Get full text
    Get full text
  2. 442

    Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 co... by Alize J, Ferrari

    Published 2024
    “…Non-communicable diseases contributed 1·73 billion (95% UI 1·54–1·94) DALYs in 2021, with a decrease in age-standardised DALY rates since 2010 of 6·4% (95% UI 3·5–9·5). …”
    Get full text
    Get full text
    Get full text
  3. 443

    Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 co... by Alize J, Ferrari

    Published 2024
    “…Non-communicable diseases contributed 1·73 billion (95% UI 1·54–1·94) DALYs in 2021, with a decrease in age-standardised DALY rates since 2010 of 6·4% (95% UI 3·5–9·5). …”
    Get full text
    Get full text
    Get full text
    article
  4. 444
  5. 445
  6. 446
  7. 447

    Health in times of uncertainty in the eastern Mediterranean region, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 by Mokdad, Ali H

    Published 2016
    “…In this systematic analysis, we use data from GBD 2013 to analyse the burden of disease and injuries in the eastern Mediterranean region specifically. …”
    Get full text
    Get full text
    Get full text
    article
  8. 448

    Turning point in COVID-19 severity and fatality during the pandemic: a national cohort study in Qatar by Chemaitelly, Hiam

    Published 2023
    “…Among all severe, critical and fatal cases, 99.5% occurred during the primary infection. Cumulative incidence of fatal COVID-19 was 0.042% (95% CI 0.036% to 0.050%), with an incidence rate of 0.13 (95% CI 0.11 to 0.16) per 1000 person years. …”
    Get full text
    Get full text
  9. 449
  10. 450
  11. 451
  12. 452
  13. 453
  14. 454
  15. 455
  16. 456

    Hybrid wind-diesel-battery system planning considering multiple different wind turbine technologies installation by Rakhshani, E.

    Published 2020
    “…Results of the case study demonstrate a significant reduction in the planning cost, namely above 5 percent depend on the wind speed. Furthermore, the total yearly energy generated by diesel generator is decreased by 700 kWh, meaning higher renewable penetration and less emissions.…”
    Get full text
    Get full text
  17. 457

    The Expression of TBC1 Domain Family, Member 4 (TBC1D4) in Skeletal Muscles of Insulin-Resistant Mice in Response to Sulforaphane by Rizk, Nasser M

    Published 2020
    “…Results: SFN-treated DIO mice had significantly lower non-fasting blood glucose levels than vehicle-treated mice (194.16 ± 14.12 vs. 147.44 ± 20.31 mg/dL, vehicle vs. SFN, p value=0.0003). …”
    Get full text
    Get full text
  18. 458

    Oxygen passivation as effective technique for tailoring the nature of band gap of silicon nanowires by Hassan, Walid M.I.

    Published 2015
    “…Surprisingly, extensive oxidation dramatically decreases the silicon nanowire band gap down to 0.26 eV. …”
    Get full text
    Get full text
    Get full text
  19. 459
  20. 460

    In vitro evaluation of Neosetophomone B inducing apoptosis in cutaneous T cell lymphoma by targeting the FOXM1 signaling pathway by Kuttikrishnan, Shilpa

    Published 2023
    “…Objective: In this study, we investigated the anti-cancer potential of Neosetophomone B (NSP-B), a fungal-derived secondary metabolite, on CTCL cell lines H9 and HH. …”
    Get full text
    Get full text